| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/23/2007 | EP1786384A1 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 05/23/2007 | EP1786265A2 Novel compositions and methods of treatment |
| 05/23/2007 | EP1585743B1 2-(1h-indazol-6-ylamino)- benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 05/23/2007 | EP1560576A4 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 05/23/2007 | EP1539211A4 Method of up-regulating tumor antigen expression using thymalfasin |
| 05/23/2007 | EP1530494B1 A pharmaceutical preparation containing palladium complex compounds |
| 05/23/2007 | EP1480679B1 Pharmaceutical formulation of iressa comprising a water-soluble cellulose derivative |
| 05/23/2007 | EP1427447A4 Improved therapeutic protocols |
| 05/23/2007 | EP1423384B1 Pyridine derivatives as raf kinase inhibitors |
| 05/23/2007 | EP1417183B1 Multidentate aza ligands able to complex metal ions and the use thereof in diagnostics and therapy |
| 05/23/2007 | EP1416929A4 Cancer treatment with gö6976 and its related compounds |
| 05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 05/23/2007 | EP1296989B1 Polycyclic xanthones as antibiotics |
| 05/23/2007 | EP1238974B1 Heterocycle derivatives and drugs |
| 05/23/2007 | EP1223959B1 Inhibition of cell motility and angiogenesis by inhibitors of the grb2 sh2-domain |
| 05/23/2007 | EP1218368B1 COMPOSITIONS AND METHODS FOR MODULATING APOPTOSIS IN CELLS OVER-EXPRESSING bcl-2 FAMILY MEMBER PROTEINS |
| 05/23/2007 | EP1196427B1 C-19-halogen-substituted steroids of the androst-9(11)-ene-series, methods for the production and use thereof |
| 05/23/2007 | EP1146788B1 Indomethacin amide derivatives for antiangiogenic and/or antitumorigenic use |
| 05/23/2007 | EP1109926B1 Condensed plasmid-liposome complex for transfection |
| 05/23/2007 | EP1090146B1 Uses of dna-pk |
| 05/23/2007 | EP1015015B1 pRb2/p130 PEPTIDE INHIBITORS OF cdk2 KINASE ACTIVITY |
| 05/23/2007 | EP0873407B1 Apo-2 ligand |
| 05/23/2007 | CN1968930A Bicyclic, nitrogen-containing heterocycles aromatase inhibitors |
| 05/23/2007 | CN1968728A Use of a compound having two gold (I) atoms each covalently bonded to a carbon atom in a covalent link connecting the two gold (I) atoms for the treatment of cancer |
| 05/23/2007 | CN1968717A Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 05/23/2007 | CN1968709A VEGF inhibitors for the treatment of malignant pleural effusion |
| 05/23/2007 | CN1968706A Treatment with cisplatin and an EGFR-inhibitor |
| 05/23/2007 | CN1966684A Construction of HER2/neu mRNA in vitro transcription vector and use thereof |
| 05/23/2007 | CN1966683A Recombinant adenovirus for expression of novel tumour suppressor gene p53 |
| 05/23/2007 | CN1966529A Recombinant toxin agent containing gonadorelin and pyocyanin functional frament |
| 05/23/2007 | CN1966525A Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/23/2007 | CN1966505A Imidazole [1,2-alpha] purine derivative, method of producing same and use thereof |
| 05/23/2007 | CN1966500A Quinoxaline derivative, preparation method and uses |
| 05/23/2007 | CN1966087A Method for constructing primary liver cancer model of mice |
| 05/23/2007 | CN1966083A Tumor vaccine of fusion gene and construction method thereof |
| 05/23/2007 | CN1966082A Genetic medicine for preventing and treating cancer of colon and rectum, preparation process and use thereof |
| 05/23/2007 | CN1966015A Drink for treating cancer |
| 05/23/2007 | CN1966008A Medicated wine for treating cancer and tumor and method for preparing same |
| 05/23/2007 | CN1965988A Chinese medicine for treating tumor |
| 05/23/2007 | CN1965955A Chinese medicine for treating cancer and method for preparing same |
| 05/23/2007 | CN1965930A Duodenum targeted orally administered pharmaceutical formulation, preparation method and application thereof |
| 05/23/2007 | CN1965888A Chinese medicinal composition for treating breast cancer |
| 05/23/2007 | CN1965872A Enzymolysis extraction method of yangtao actinidia root |
| 05/23/2007 | CN1965871A An anti-tumor Chinese medicinal formulation |
| 05/23/2007 | CN1965865A Pharmaceutical application of macrothele raveni toxin |
| 05/23/2007 | CN1965830A Compound prescription of Chinese medicinal effective ingredients having anti-neovascularization synergetic effect |
| 05/23/2007 | CN1965823A Preparing methods of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4 acetylaminoisoindoline 1,3-dione and its compound |
| 05/23/2007 | CN1965809A Sustained-release microsphere of LHRH antagonist for injection and preparation process thereof |
| 05/23/2007 | CN1317303C Anti-human tenascin monoclonal antibody |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317291C Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use |
| 05/23/2007 | CN1317265C Cyanoacrylate derivatives and their preparation method and biological activity |
| 05/23/2007 | CN1317031C Efficient mixture preparation for intensifying solid tumor cell chemical therapeutic sensitivity |
| 05/23/2007 | CN1316973C Beta-carotene clathrate and its preparation method |
| 05/23/2007 | CN1316972C Anti-cancer analgetic preparation |
| 05/23/2007 | CN1316970C Solid dispersed matter of hydroxyl-camptothecin and its formulation |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220860 Anticancer agents |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220853 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 05/22/2007 | US7220834 FHIT proteins and nucleic acids and methods based thereon |
| 05/22/2007 | US7220829 Cytokine binding domain of cytokine receptors |
| 05/22/2007 | US7220784 Substituted stilbenes and their reactions |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220758 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors |
| 05/22/2007 | US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists |
| 05/22/2007 | US7220753 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders |
| 05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220575 Melanoma differentiation associated gene-5 and promoter and uses thereof |
| 05/22/2007 | US7220559 Development of human monoclonal antibodies and uses thereof |
| 05/22/2007 | US7220551 Vaccine containing human papillomarus virus antigen, aluminum hydroxide and a preferential stimulator of TH1 cell response such as 3 De-O-acylated monophosphoryl lipid A (3D-MPL) |
| 05/22/2007 | US7220428 Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells |
| 05/22/2007 | US7220425 Method for therapy of liver tumors |
| 05/22/2007 | US7220419 Self-assembling recombinant papillomavirus capsid proteins |
| 05/22/2007 | US7220399 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2212200C Novel inhibitors of .beta.-glucuronidase |
| 05/22/2007 | CA2208241C Stable solutions of 2-chloro-2'-deoxyadenosine formulations |
| 05/22/2007 | CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof |
| 05/18/2007 | WO2007056596A2 Phosphoramidate derivatives of fau |
| 05/18/2007 | WO2007056468A1 Methods for inhibiting protein kinases |
| 05/18/2007 | WO2007056435A2 Dynamin mediated diseases and associated methods and products |
| 05/18/2007 | WO2007056151A2 Protein kinase inhbitors |
| 05/18/2007 | WO2007055926A1 Negative immunomodulation of immune responses by nkg2d-positive cd4+ cells |
| 05/18/2007 | WO2007055902A1 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/18/2007 | WO2007055514A1 Quinazoline derivatives as a multiplex inhibitor and method for the preparation thereof |
| 05/18/2007 | WO2007055513A1 Quinazoline derivatives as a signal transduction inhibitor and method for the preparation thereof |
| 05/18/2007 | WO2007054954A1 A novel pyrrolo[2,1-c][1,4]benzodiazepine hybrid and a process for the preparation thereof |
| 05/18/2007 | WO2007054814A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | WO2007054748A1 Indole derivatives as antitumoural compounds |
| 05/18/2007 | WO2007054731A1 Antiproliferative combination comprising cyc-682 and a cytotoxic agent |
| 05/18/2007 | WO2007054725A2 Combination of a cdk-inhibitor and a hdac-inhibitor |
| 05/18/2007 | WO2007054719A2 Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent |
| 05/18/2007 | WO2007054717A2 STAUROSPORINE DERIVATIVES FOR THE TREATMENT OF LEUKEMIA CHARACTERISED BY A SPTBNl -FLT3 MUTATION |